Lung-targeting lipid nanoparticles with CRISPR components successfully treat cystic fibrosis mouse models

A team of medical researchers from the University of Texas Southwestern Medical Center, Case Western Reserve University School of Medicine and ReCode Therapeutics has developed a way to send gene-editing tools to the lungs to repair the faulty gene associated with cystic fibrosis.